Powder: -20°C for 3 years | In solvent: -80°C for 1 year
YS-49 is an activator of PI3K/Akt (a downstream target of RhoA).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
2 mg | In stock | $ 56.00 | |
5 mg | In stock | $ 92.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 289.00 | |
50 mg | In stock | $ 429.00 | |
100 mg | In stock | $ 622.00 | |
500 mg | In stock | $ 1,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | YS-49 is an activator of PI3K/Akt (a downstream target of RhoA). |
In vitro | In RAVSMC and RAW 264.7 cells, YS-49 (1-100?μM; 18 hours; ) concentration-dependently inhibits the accumulation of nitrite in both RAVSMC and RAW 264.7 exposed to lipopolysaccharide (LPS) plus INF-γ, with IC50 values of 22 μM and 30?μM, respectively[2].At the transcriptional level, YS-49 (10-100?μM; 18 hours; RAVSMC and RAW 264.7 cells) suppresses iNOS gene expression induced by LPS and/or cytokines in RAVSMC and RAW 264.7 cells [2]. |
In vivo | In male Sprague Dawley rats,YS-49 (5?mg/kg; intraperitoneal injection; 8 hours) treatment significantly reduces serum NOx levels in LPS-treated rats, the NOx levels reduce from 86 μM to 34 μM[2]. |
Molecular Weight | 386.28 |
Formula | C20H20BrNO2 |
CAS No. | 132836-42-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 10 mg/mL (25.89 mM), Sonification and heating to 60℃ are recommended.
DMSO: 100 mg/mL (258.88 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
YS-49 132836-42-1 Cytoskeletal Signaling Endocrinology/Hormones GPCR/G Protein Neuroscience PI3K/Akt/mTOR signaling PI3K Akt RAAS Adrenergic Receptor inhibit YS49 Phosphoinositide 3-kinase PKB Beta Receptor YS 49 Protein kinase B Inhibitor Angiotensin Receptor inhibitor